4.5 Editorial Material

PROTAC cell permeability and oral bioavailability: a journey into uncharted territory

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

PROTAC-DB: an online database of PROTACs

Gaoqi Weng et al.

Summary: PROTACs, a novel therapeutic technology that selectively degrades targeted proteins, has achieved significant progress with two PROTACs in phase I clinical trials. However, the design of PROTACs remains challenging. PROTAC-DB, a web-based database, integrates structural information and experimental data of PROTACs, providing convenient querying and filtering tools for researchers.

NUCLEIC ACIDS RESEARCH (2021)

Article Chemistry, Medicinal

Solution Conformations Shed Light on PROTAC Cell Permeability

Yoseph Atilaw et al.

Summary: PROTACs induce intracellular degradation of target proteins through a bifunctional structure. Structural insights into a VHL-based PROTAC revealed elongated and polar conformations in solutions, suggesting the importance of molecular chameleonicity for cell permeability.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

Article Chemistry, Medicinal

Unraveling the Role of Linker Design in Proteolysis Targeting Chimeras

Troy A. Bemis et al.

Summary: A current bottleneck in the development of PROTACs is the empirical nature of linker length structure-activity relationships. A multi-disciplinary approach has been detailed to alleviate this bottleneck. Research has focused on synthetic approaches to increase throughput, advances in structural biology and computational chemistry for rational PROTAC design, and de novo linker design in silico.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Multidisciplinary

Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic Drugs

Emma Danelius et al.

CHEMISTRY-A EUROPEAN JOURNAL (2020)

Review Pharmacology & Pharmacy

Fundamental aspects of DMPK optimization of targeted protein degraders

Carina Cantrill et al.

DRUG DISCOVERY TODAY (2020)

Review Pharmacology & Pharmacy

Degraders early developability assessment: face-to-face with molecular properties

Giuseppe Ermondi et al.

DRUG DISCOVERY TODAY (2020)

Article Chemistry, Medicinal

Understanding and Improving the Membrane Permeability of VH032-Based PROTACs

Victoria G. Klein et al.

ACS MEDICINAL CHEMISTRY LETTERS (2020)

Article Chemistry, Medicinal

Systematic Investigation of the Permeability of Androgen Receptor PROTACs

Duncan E. Scott et al.

ACS MEDICINAL CHEMISTRY LETTERS (2020)

Article Chemistry, Medicinal

Predicting the Permeability of Macrocycles from Conformational Sampling – Limitations of Molecular Flexibility

Vasanthanathan Poongavanam et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Review Chemistry, Medicinal

Proteolysis targeting chimeras (PROTACs) in 'beyond rule-of-five' chemical space: Recent progress and future challenges

Scott D. Edmondson et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)

Article Biochemistry & Molecular Biology

PROTAC-Mediated Degradation of Bruton's Tyrosine Kinase Is Inhibited by Covalent Binding

Christopher P. Tinworth et al.

ACS CHEMICAL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

Developing degraders: principles and perspectives on design and chemical space

Hannah J. Maple et al.

MEDCHEMCOMM (2019)

Article Chemistry, Medicinal

Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection

David A. DeGoey et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

DrugBank 5.0: a major update to the DrugBank database for 2018

David S. Wishart et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Chemistry, Multidisciplinary

Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations?

Vasanthanathan Poongavanam et al.

ACS OMEGA (2018)

Review Biochemistry & Molecular Biology

Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates

Bradley Croy Doak et al.

CHEMISTRY & BIOLOGY (2014)